// App-Quantinova.ai

466 : Antithrombin III Administration for Portal Vein Thrombosis in Patients with Cirrhosis: A Randomized Double‐Blind Controlled Trial

Researchers

Presenter

  • Hisashi Hidaka

Principal Investigators

  • Shigehiro Kokubu

  • Shinji Katsushima

  • Namiki Izumi

  • Takumi Igura

  • Shingo Asahara

  • Kazuo Notsumata

  • Yukio Osaki

  • Keiji Tsuji

  • Hirofumi Kawanaka

  • Tomohiko Akahoshi

Medical Centers

  • Department of Gynecology, Kitasato University School of Medicine, Sagamihara, Japan

  • Institute for Liver Disease Minimal Invasive Treatment, Shinyurigaoka General Hospital, Kawasaki, Japan

  • Department of Obstetrics and Gynecology, National Hospital Organization, Kyoto Medical Center, Kyoto, Japan

  • Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  • Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan

  • Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan

  • Department of Internal Medcine, FukuiKen Saiseikai Hospital, Fukui, Japan

  • Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  • Department of Surgery, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan

  • Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Venous thrombosis

  • Cirrhosis

Biomarkers

  • Antithrombin III

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • NCT02250391

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved